Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen

NCT02974361 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Ibuprofen
DRUG: Ibuprofen Lysine
DRUG: Ibuprofen-LDH

Sponsor

Oxford Pharmascience Ltd